GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Long-Term Capital Lease Obligation

DaVita (BSP:DVAI34) Long-Term Capital Lease Obligation : R$11,418 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is DaVita Long-Term Capital Lease Obligation?

DaVita's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was R$11,418 Mil.

DaVita's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (R$11,574 Mil) to Sep. 2023 (R$11,567 Mil) and declined from Sep. 2023 (R$11,567 Mil) to Dec. 2023 (R$11,418 Mil).

DaVita's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (R$15,114 Mil) to Dec. 2022 (R$13,130 Mil) and declined from Dec. 2022 (R$13,130 Mil) to Dec. 2023 (R$11,418 Mil).


DaVita Long-Term Capital Lease Obligation Historical Data

The historical data trend for DaVita's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Long-Term Capital Lease Obligation Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,179.84 14,089.64 15,113.93 13,129.59 11,418.44

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,129.59 12,787.86 11,573.51 11,567.28 11,418.44

DaVita  (BSP:DVAI34) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

DaVita Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of DaVita's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (BSP:DVAI34) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines